ImmunityBio (IBRX) EBT Margin (2014 - 2026)
ImmunityBio's EBT Margin was -449.63% in Q2 2026, down 100.32 percentage points from -349.31% a year earlier but up 981.82 percentage points from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) EBT Margin (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, ImmunityBio's EBT Margin was -598.69% through Jun 30, 2026, up 49.96 percentage points year-over-year; for FY2025, it came in at -310.37%, up 2494.96 percentage points from FY2024.
- EBT Margin has now increased for three consecutive years, with a five-year change of +37050.46 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -2805.32% in FY2024 (+91067.99 pp), -93873.31% in FY2023 (+79995.85 pp), -173869.17% in FY2022 (-136413.17 pp) and -37456.00% in FY2021 (-95.17 pp).
- Quarterly EBT Margin has moved between -735700.00% (Q1 2022) and -162.19% (Q4 2025) over five years.
- Compared with a year earlier, EBT Margin was higher in six of the last eight quarters, with an average year-over-year change of +78814.39 percentage points.
- The best year-over-year quarter for EBT Margin over five years was Q1 2023 (a gain of 703315.83 percentage points); the worst was Q1 2022 (a drop of 677804.32 percentage points).
- Per Business Quant data, IBRX's EBT Margin in the three quarters before Q2 2026 was -1431.45% (Q1 2026), -162.19% (Q4 2025) and -209.94% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | -449.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -449.63% |
| Mar 31, 2026 | -1,431.45% |
| Dec 31, 2025 | -162.19% |
| Sep 30, 2025 | -209.94% |
| Jun 30, 2025 | -349.31% |
| Mar 31, 2025 | -786.46% |
| Dec 31, 2024 | -783.62% |
| Sep 30, 2024 | -1,404.39% |
| Jun 30, 2024 | -12,854.25% |
| Mar 31, 2024 | -335,325.00% |
| Dec 31, 2023 | -167,952.52% |
| Sep 30, 2023 | -116,636.59% |
| Jun 30, 2023 | -337,104.88% |
| Mar 31, 2023 | -32,384.17% |
| Dec 31, 2022 | -148,345.21% |
| Sep 30, 2022 | -94,204.24% |
| Jun 30, 2022 | -270,957.14% |
| Mar 31, 2022 | -735,700.00% |
| Dec 31, 2021 | -23,474.87% |
| Sep 30, 2021 | -133,983.33% |
API Access
ImmunityBio EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();